<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00793676</url>
  </required_header>
  <id_info>
    <org_study_id>4171</org_study_id>
    <nct_id>NCT00793676</nct_id>
  </id_info>
  <brief_title>Asthma, Inflammation and G Protein-coupled Receptors (GPCR)</brief_title>
  <official_title>G Protein Coupled Receptor (GPCR)Signature as Biomarker of Chronic Pulmonary Inflammatory Diseases and of Therapeutic Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The G protein-coupled receptors (GPCRs) are a family of proteins expressed at the cell
      membrane. They are composed of 380 members involved in the important functions of the
      organism and are privileged therapeutic targets.Their expression is highly modulated
      depending on the metabolic state of the cells, in particular in pathological situations.our
      study proposes to determine whether GPCR expression modulation could be used as a biomarker,
      either prognostic or diagnostic, of treatments.To do so , the investigators will determine
      the expression profile of the 380 human GPCRs in human blood cell samples in two chronic
      inflammatory pulmonary diseases : asthma and COPD (chronic obstructive pulmonary disease ) .
      These have opposed inflammatory infiltrates : asthma is associated with eosinophil and Th2
      lymphocyte infiltration whereas COPD shows neutrophils and macrophages within the airways
      with a Th1 lymphocytic population. The GPCR signature (transcriptomic) will be determined on
      total white blood cells as well as on isolated mono- and poly-nuclear populations obtained
      from healthy subjects and patients selected at the asthma or COPD consultation. The
      expression profiling analysis will reveal sub-groups of GPCRs whose expression is modified in
      disease. The specificity of the variation of expression of these biomarker sub-populations
      will be determined, by a study recruiting a hundred patients and controls per disease on this
      restraint number of genes. The outcomes of the project will lead to establish GPCR &quot;identity
      cards&quot; for these chronic inflammatory diseases, which might therefore be used as diagnostic
      or prognostic biomarkers to follow the evolution of a disease or the efficacy of a given
      treatment. In addition, detailed analysis of the identified GPCRs will lead to propose new
      therapeutic targets for inflammatory diseases. This study has therefore the objective of
      validating GPCRs as potential biomarkers for inflammatory diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentre non-randomized
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>differential expression of GPCRs</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">205</enrollment>
  <condition>Asthma</condition>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>A= Asthma</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B= COPD</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C= Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spirometry</intervention_name>
    <arm_group_label>A= Asthma</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood test</intervention_name>
    <arm_group_label>A= Asthma</arm_group_label>
    <arm_group_label>B= COPD</arm_group_label>
    <arm_group_label>C= Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma group

          -  COPD group

          -  Control group

        Exclusion Criteria:

          -  Patients with infection or inflammatory diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romain Kessler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pascal Chanez</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Antoine Magnan</name>
      <address>
        <city>Nantes</city>
        <zip>44035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2008</study_first_submitted>
  <study_first_submitted_qc>November 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2008</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>GPCR expression</keyword>
  <keyword>transcriptomic</keyword>
  <keyword>white blood cells</keyword>
  <keyword>diagnostic</keyword>
  <keyword>Control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

